Mankind Pharma Limited has informed the Exchange about Incorporation
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mankind Pharma has incorporated a wholly owned subsidiary named 'KINDCARE FOUNDATION' on June 2, 2025. The new entity is registered as a Section 8 company under the Companies Act, 2013, which means it is a non-profit structure typically used for charitable, social welfare, or CSR activities. This follows an earlier intimation made to the exchanges on April 14, 2025. No financial details, capital investment, or business objectives were disclosed in this filing beyond the incorporation itself.
This is a routine CSR-related incorporation and is unlikely to have a material impact on Mankind Pharma's stock price or core business operations. It signals the company's intent to formalize its social or philanthropic initiatives through a dedicated non-profit vehicle.